We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AACC and Life Diagnostics Partner to Relaunch AACC Middle East

By LabMedica International staff writers
Posted on 10 Feb 2022

The American Association for Clinical Chemistry (AACC Washington, D. More...

C., USA) has announced a new collaboration with Life Diagnostics (Abu Dhabi, UAE) to relaunch AACC Middle East which will bring AACC's world-renowned education and scientific programs paired with a dynamic exhibit to Dubai, UAE, November 5-6, 2022.

AACC Middle East was first launched in 2018 as part of AACC's strategy to improve health outcomes globally, and it drew an overwhelmingly positive response during its initial two-year run. Like so many in-person events, it then went on hiatus after the emergence of COVID-19. However, as the pandemic has persisted and continued to challenge laboratory medicine professionals - the people on the frontlines of coronavirus testing worldwide - it has become more important than ever that AACC Middle East be resumed in order to provide lab professionals with the educational programming and networking opportunities they need at this crucial time.

AACC will work closely with Life Diagnostics in order to relaunch AACC Middle East for this purpose. The event's scientific program will feature experts from the US and the Middle East who will share gold standard, actionable information about the latest in clinical testing. Attendees will be able to come together safely and in-person with leaders in the field to share lessons learned from the pandemic to date. In addition, the exposition floor of AACC Middle East will feature the latest innovations in every area of clinical testing, including coronavirus testing, artificial intelligence (AI), mobile health, molecular diagnostics, mass spectrometry, next-generation sequencing (NGS), point of care (POC), and automation.

"We at AACC are very excited to partner with Life Dx and other content experts in the Middle East to bring this essential conference back to the region," said AACC President Dr. Stephen R. Master. "For the past two years, laboratory medicine professionals around the world have heroically risen to the challenges we've faced during the pandemic, and I hope this meeting will fuel attendees' innovation and create new research collaborations and connections with colleagues who understand what everyone in the field has been through over these past many months."

Related Links:
AACC 
Life Diagnostics 


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Portable Electronic Pipette
Mini 96
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Specimen Radiography System
TrueView 200 Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: GeneseeqPrime analyzes 425 cancer-related genes by next-generation sequencing (Photo courtesy of Geneseeq)

Comprehensive Tumor Profiling Kit Decentralizes and Standardizes Oncology Testing

Cancer remains one of the leading global health burdens, with accurate and timely tumor profiling critical to guiding treatment decisions. Traditional approaches often struggle to capture the full range... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.